Additive Therapy of <i>Plasmodium berghei</i>-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin.

Microbiol Spectr · 2023 · PMC10101104 · PMID 36946739

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In combination therapy, all groups of mice showed a decreasing trend in rapid murine coma and behavioral scale (RMCBS) scores ( Fig. 1B ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Additive Therapy of &lt;i&gt;Plasmodium berghei&lt;/i&gt;-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin.

The sentences

Additive Therapy of <i>Plasmodium berghei</i>-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin.